Does the Amount of Malignant Pleural Effusion Affect the Survival in Patients with Non-Small Cell Lung Cancer?

被引：0
|
作者：
Nakamura, Shota [1 ]
Okasaka, Toshiki [1 ]
Kawaguchi, Koji [1 ]
Fukui, Takayuki [1 ]
Fukumoto, Koichi [1 ]
Yokoi, Kohei [1 ]
机构：
[1] Nagoya Univ, Thorac Surg, Nagoya, Aichi 4648601, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
non-small cell lung cancer; TNM classification; malignant pleural effusion; malignant pleuritis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.04-128
引用
收藏
页码：S727 / S727
页数：1
相关论文
共 50 条
  • [11] Molecular profile of malignant pleural effusion (MPE) in non-small cell lung cancer (NSCLC)
    Rodriguez, Irene Lojo
    Rial, Maribel Botana
    Montaos, Almudena Gonzalez
    Pineiro, Ana Gonzalez
    Hernandez, Cristina Ramos
    Delgado, Mercedes Cuna
    Delgado, Manuel Nunez
    Villar, Alberto Fernandez
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [12] EGFR mutations in malignant pleural effusion of non-small cell lung cancer:: A case report
    Huang, MJ
    Lim, KH
    Tzen, CY
    Hsu, HS
    Yen, Y
    Huang, BS
    LUNG CANCER, 2005, 49 (03) : 413 - 415
  • [13] Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion
    Hao Zeng
    Yuanyuan Zhang
    Sihan Tan
    Qin Huang
    Xin Pu
    Panwen Tian
    Yalun Li
    BMC Pulmonary Medicine, 24
  • [14] Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion
    Li, Tianyuan
    Tian, Panwen
    Huang, Qin
    Zeng, Hao
    Wei, Qi
    Li, Yalun
    CLINICAL RESPIRATORY JOURNAL, 2023, 17 (11): : 1158 - 1168
  • [15] The efficacy of osimertinib in patients with EGFR-positive non-small cell lung cancer with malignant pleural effusion
    Kiritani, Ayu
    Amino, Yoshiaki
    Uchibori, Ken
    Akita, Takahiro
    Harutani, Yuhei
    Ogusu, Shinsuke
    Tsugitomi, Ryosuke
    Manabe, Ryo
    Ariyasu, Ryo
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    ANNALS OF ONCOLOGY, 2022, 33 : S510 - S511
  • [16] Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion
    Zeng, Hao
    Zhang, Yuanyuan
    Tan, Sihan
    Huang, Qin
    Pu, Xin
    Tian, Panwen
    Li, Yalun
    BMC PULMONARY MEDICINE, 2024, 24 (01)
  • [17] Prognostic Significance of Minimal Pleural Effusion in Non-small Cell Lung Cancer Patients
    Ryu, Jeong Seon
    Ryu, Hyo-Jin
    Nam, Hae-Seong
    Kim, Hyun-Jung
    CHEST, 2013, 144 (04)
  • [18] SIGNIFICANCE OF MINIMAL PLEURAL EFFUSION IN NON-SMALL CELL LUNG CANCER
    Martin, G. A.
    Tsim, S.
    MacLay, J.
    Stewart, C.
    Blyth, K. G.
    THORAX, 2016, 71 : A86 - A86
  • [19] Relationship of clinicopathological characteristics, EGFR genotyping and prognosis in non-small cell lung cancer patients with malignant pleural effusion
    Zhang, J.
    Zhou, Z. S.
    Su, Y. C.
    Yu, T. Q.
    ANNALS OF ONCOLOGY, 2019, 30
  • [20] Efficacy of osimertinib in patients with EGFR-mutation positive non-small cell lung cancer with malignant pleural effusion
    Kiritani, Ayu
    Amino, Yoshiaki
    Uchibori, Ken
    Akita, Takahiro
    Harutani, Yuhei
    Ogusu, Shinsuke
    Tsugitomi, Ryosuke
    Manabe, Ryo
    Ariyasu, Ryo
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    THORACIC CANCER, 2024, 15 (05) : 402 - 409
12345